BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18554073)

  • 21. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.
    Kramer JM; Hammill B; Anstrom KJ; Fetterolf D; Snyder R; Charde JP; Hoffman BS; Allen LaPointe N; Peterson E
    Am Heart J; 2006 Sep; 152(3):454.e1-8. PubMed ID: 16923412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder.
    Pelletier EM; Vats V; Clemens JQ
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S108-14. PubMed ID: 19355799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BRNO Register 2: post-myocardial infarction pharmacotherapy].
    Spinar J; Ludka O; Sepsi M; Schildberger J; Dusek L; Jarkovský J;
    Vnitr Lek; 2010 Jun; 56(6):533-40. PubMed ID: 20681466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Fang W; Oreopoulos DG; Bargman JM
    Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population.
    Amin AP; Mukhopadhyay E; Nathan S; Napan S; Kelly RF
    Transl Res; 2009 Aug; 154(2):78-89. PubMed ID: 19595439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension management in outpatient visits by diabetic patients.
    Aparasu RR; Aparasu A
    Res Social Adm Pharm; 2008 Sep; 4(3):284-91. PubMed ID: 18794038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension.
    Robertson TA; Cooke CE; Wang J; Shaya FT; Lee HY
    Am J Manag Care; 2008 Nov; 14(11):710-6. PubMed ID: 18999905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in management of elderly patients with myocardial infarction.
    Schiele F; Meneveau N; Seronde MF; Descotes-Genon V; Oettinger J; Ecarnot F; Bassand JP;
    Eur Heart J; 2009 Apr; 30(8):987-94. PubMed ID: 19176538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence with statins over 8 years in a usual care setting.
    Vinker S; Shani M; Baevsky T; Elhayany A
    Am J Manag Care; 2008 Jun; 14(6):388-92. PubMed ID: 18554077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
    Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy.
    Kirchmayer U; Agabiti N; Belleudi V; Davoli M; Fusco D; Stafoggia M; Arcà M; Barone AP; Perucci CA
    J Clin Pharm Ther; 2012 Feb; 37(1):37-44. PubMed ID: 21294760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
    Fonarow GC; Gawlinski A; Watson K
    Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
    Liou YS; Ma T; Tien L; Lin CM; Jong GP
    Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways.
    Corbelli JC; Janicke DM; Cziraky MJ; Hoy TA; Corbelli JA
    Am Heart J; 2009 Jan; 157(1):61-8. PubMed ID: 19081398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.